Atherogenic dyslipidemia—before or during pregnancy—may contribute to preeclampsia
and subsequent cardiovascular disease risk. We performed a nested case-control study to …

The pregnancy disorder preeclampsa is characterized by endothelial cell dysfunction that
may be promoted by abnormal increases in circulating lipids, particularly triglycerides and …

OBJECTIVE:: To determine whether large triglyceride-rich lipoproteins, very-low-density
lipoprotein1 (VLDL1), and small, dense low-density lipoprotein (LDL-III), are significantly …

A link may exist between preeclampsia/eclampsia and development of cardiovascular
disease in later life (Acta Obstet Gynecol Scand 1995; 74: 772). Several lipid changes …

Objective: To characterize the changes in low-density lipoprotein (LDL) peak particle
diameter (diameter of the predominant LDL subclass) in relation to changes in serum …

Study design In a prospective cohort study, maternal blood samples were collected at 13
weeks' gestation on average. From the cohort, we selected 57 women who developed …

The aim of this study was to evaluate changes in lipids, apolipoproteins and lipoproteins in
Portuguese pregnant women and their potential involvement in the pathophysiology of …

Late pregnancy is a unique metabolic state where there are transient increases in the
concentrations of plasma triglyceride (TG), cholesterol, and apolipoprotein (apo) B. Despite …

We investigated the changes of low—density Iipoprotein (LDL) size and serum lipids during
pregnancy and postpartum not only in normal pregnant women but also in preeclampsia …

Disorders of the lipoprotein metabolism are a major cause of endothelial dysfunction that
may result in hypertension and proteinuria, clinical hallmarks of preeclampsia (PE) …